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ABSTRACT Peak oxygen uptake (V′O2peak) is recognised as the best expression of aerobic fitness.
Therefore, it is essential that V′O2peak reference values are accurate for interpreting a cardiopulmonary
exercise test (CPET). These values are country specific and influenced by underlying biological ageing
processes. They are normally stratified per paediatric and adult population, resulting in a discontinuity at
the transition point between prediction equations. There are currently no age-related reference values
available for the lifespan of individuals in the Dutch population. The aim of this study is to determine the
best-fitting regression model for V′O2peak in the healthy Dutch paediatric and adult populations in relation
to age.
In this retrospective study, CPET cycle ergometry results of 4477 subjects without reported somatic
diseases were included (907 females, age 7.9–65.0 years). Generalised additive models were employed to
determine the best-fitting regression model. Cross-validation was performed against an independent
dataset consisting of 3518 subjects (170 females, age 6.8–59.0 years).
An additive model was the best fitting with the largest predictive accuracy in both the primary (adjusted
R2=0.57, standard error of the estimate (SEE)=556.50 mL·min−1) and cross-validation (adjusted R2=0.57,
SEE=473.15 mL·min−1) dataset.
This study provides a robust additive regression model for V′O2peak in the Dutch population.
@ERSpublications
Peak oxygen uptake has a nonlinear dependence on years of age in the paediatric and adult
Dutch populations http://ow.ly/H3fH30nIjRy
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Peak oxygen uptake (V′O2peak) represents the functional limit of the body’s ability to deliver and extract
oxygen in muscles in order to satisfy the metabolic demands of vigorous exercise; it is recognised as the
best expression of aerobic fitness [1]. V′O2peak is increasingly utilised to optimise risk stratification and to
facilitate clinical decision making because it reflects therapeutic response and predicts adverse events such
as post-operative complications and mortality after abdominal and thoracic surgery [2–5].
For the interpretation of a cardiopulmonary exercise test (CPET), it is essential to have accurate V′O2peak
reference values corresponding with the ergometer used [7, 8]. These values are region or country specific,
and change over time due to cultural differences and evolving population characteristics [8, 9]. Therefore,
each country must have specific updated V′O2peak reference values that optimally reflect the characteristics
of the current population tested, the equipment and the methodology utilised [8–10]. Although multiple
countries provided up-to-date V′O2peak reference values derived from large cohorts exceeding 4000
participants [11–13], V′O2peak reference values from 1985 are the most commonly used in clinical settings
in the Netherlands as there are none available derived for the Dutch adult population [14]. These
commonly used V′O2peak reference value prediction equations were obtained from a relatively small sample
of 100 participants from the North American population [14].
V′O2peak is highly influenced by underlying biological ageing processes such as physical development,
pubertal status, age-induced neuromuscular deterioration, sarcopenia and cardiopulmonary decline [7, 15,
16]. It has been hypothesised in both the paediatric and adult populations that V′O2peak develops in a
nonlinear and interrelated manner with the progression of age [7, 17–20]. Linear regression models are
predominantly used to determine V′O2peak reference value prediction equations depending upon sex, age,
height, weight and physical activity levels [9, 14, 16, 21].
The frequently used age stratification between the paediatric and adult populations is somewhat arbitrary, and
it introduces a discontinuity at the transition point between the two equations, which leads to a reference value
shift from the paediatric to the adult population. Additionally, such an age stratification implies more
prediction uncertainty as accuracy is lowest at the boundary of the sample age scale. Estimation of an
up-to-date general prediction model across the paediatric as well as the adult population would facilitate a
smooth transition into adult care. Therefore, the aim of this study is to determine the best-fitting regression
model for V′O2peak in the healthy Dutch paediatric and adult populations in relation to age.
Methods
This retrospective multicentre study was conducted using the LowLands Fitness Registry [6], a primary
dataset of 8900 subjects from 11 healthcare centres in the Netherlands that was aggregated with the aim of
establishing CPET reference values for the Dutch population. Additionally, to determine the external and
predictive validity of the reference value prediction model, a cross-validation procedure was performed on
an independent sample as recommended by the American Thoracic Society/American College of Chest
Physicians (ATS/ACCP) [8]. Specifically, the cross-validation in this study was performed against an
additional dataset obtained from the Diving Medical Center (Den Helder, The Netherlands) and the
Wilhelmina Children’s Hospital (Utrecht, The Netherlands). The cross-validation dataset contained 4536
subjects that were not included in the primary dataset. Both datasets contain incremental CPET
measurements collected between January 2010 and December 2016. Institutes that were included satisfied
the following criteria: 1) to meet the ATS/ACCP statement equipment requirements to perform an
incremental CPET using an electromagnetically braked cycle ergometry test utilising gas exchange analysis
by bag collection, mixing chamber or breath-by-breath analysis based upon averaging the values measured
during the last 30–60 s of the test [8] and 2) to perform equipment quality control in accordance with the
ATS/ACCP statement [8].
Subjects included in both datasets underwent an individualised incremental CPET cycle ergometry test for
multiple reasons, including: initiated by a healthcare professional, work- and sports-related (mandatory)
annual health checks, participation in scientific studies or based on personal motivation (e.g. an exercise
response evaluation for the aid of a training scheme). Every institute provided anonymised, coded patient
information to the data coordinator at the University Medical Center Utrecht (Utrecht, The Netherlands).
All records were previously screened for measurement failures. If there were any uncertainties, the testing
institute was contacted to ensure the communication of correct data. It has been confirmed by the medical
ethical research committee of the University Medical Center Utrecht that the Dutch Medical Research
Involving Human Subjects (WMO) Act does not apply to the current study.
Study sample
All of the subjects included in the study were Dutch residents, aged ⩽65 years. The status “healthy” was
defined as the absence of any reported somatic signs of disease and the exclusion of registered available
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risk factors [22]. Therefore, subjects were excluded if they reported somatic diseases at the time of testing
or showed ECG irregularities prior to testing. Additionally, subjects were excluded from further analysis if
they included a missing predictor or outcome values. To ensure subjects reached their maximal
measurement (i.e. V′O2peak), subjects were excluded if they did not reach a respiratory exchange peak ratio
of at least 1.0 [23] or did not reach a minimum of 85% of the age-predicted maximum heart rate
(beats·min−1) determined as 208−(0.7×age) [24]. Furthermore, due to the abnormal working capacity and
cardiovascular responses to exercise in underweight patients and the recognition of obesity as a disease by
the World Health Organization, subjects who had a body mass index (BMI) ⩾30 kg·m−2 [25] or, in adult
subjects, ⩽18.5 kg·m−2 [26] were excluded. Due to the decrease in V′O2peak associated with smoking,
subjects who actively smoked at the time of the test were excluded [27]. Lastly, professional athletes were
excluded because they were considered as not representative for the average Dutch population due to the
positive effects of exercise training on V′O2peak [28]. The exclusion criteria were applied in both the
primary and cross-validation datasets.
Statistical analyses
Statistical analyses were performed using R version 3.4.4 [29]. A p-value ⩽0.05 was considered significant.
Continuous data were summarised as mean with standard deviation and categorical data as frequencies
(percentage). The variables sex, age, weight and height were included in the analyses as these are
commonly used as a basis for V′O2peak reference value prediction equations [9].
Generalised additive models (GAMs) were utilised to semiparametrically find the most appropriate fitting
regression model [30, 31]. To determine the model best fitting the data, criteria such as the adjusted R2,
Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) were used [32, 33]. A
higher adjusted R2 and a lower AIC and BIC were considered as improving the fit. In cases of
inconsistency between these, the BIC criterion was taken as the most decisive. The interpretation of the
BIC score was: 0–2 as “minimal” improvement, 2–6 as “positive” improvement, 6–10 as “strong”
improvement and >10 as “very strong” improvement [34].
All models fitted to the data included an age by sex interaction term to account for the different V′O2peak
levels between male and female subjects [11]. In order to compare with a best-performing polynomial
regression model, each predictive variable was modelled using linear, quadratic and cubic effects by
stepwise minimum BIC procedures [35]. The resulting model was employed to represent the polynomial
model type in the model fitting procedures. Additionally, based upon the hypothesised nonlinear age
dynamics for V′O2peak, an additive model with a smooth spline type of transformation for age was
included [17–20, 31].
To determine the fit of the models in the separate paediatric and adult populations, the predictive accuracy
of the models was measured using stratified age groups by comparing the residual standard error of the
estimate (SEE). The groups were stratified by ⩽20 and >20 years of age. The better the predictive fit of
either of the three types of models, the less variability there is and the smaller the standard error of the
estimate [36].
Models are of little clinical value unless these have predictive accuracy for independent samples. A
cross-validation procedure was performed using each identified model per type (linear, polynomial and
GAM) against a cross-validation dataset. Similar to criteria for the primary analysis, the model
performance was evaluated by a larger adjusted R2 and a smaller standard error of the estimate.
For the purpose of illustration, examples of V′O2peak predictions are reported using the best-performing
regression model. For these examples, cases with an increase of 5 years per paediatric case and 10 years
per adult case are used; corresponding average height and weight were used determined by data provided
by Statistics Netherlands (www.cbs.nl). The 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th and 97.5th
prediction percentile intervals are reported.
Results
The complete registry consisted of 8900 cases (1641 females); after applying the exclusion criteria for
missing values (n=2674), nonmaximal tests (n=480), BMI ⩾30 kg·m−2 or, in adults, ⩽18.5 kg·m−2
(n=324), smokers (n=881) and professional athletes (n=64), a sample of 4477 cases labelled as “healthy”
remained (907 females) with age ranging from 7.9 to 65.0 years. The cross-validation sample contained
4536 subjects; after applying the exclusion criteria for missing values (n=0), nonmaximal tests (n=64),
BMI ⩾30 kg·m−2 or, in adults, ⩽18.5 kg·m−2 (n=260), smoking (n=694) and professional athletes (n=0), a
sample of 3518 subjects (170 females) with an age range from 6.8 to 59.0 years remained. Table 1
summarises the characteristics of both samples. Figure 1 shows the age distribution of the primary sample.
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The best-performing polynomial regression model that was found via stepwise minimum BIC was:
V′O2peak (mL·min−1)=−1469+(673.00×sex)+(16.87×age)+(−0.47×age2)+(0.07×height2)+(39.70×weight)+
(−0.16×weight2) (adjusted R2=0.56, AIC=69480.15, BIC=69531.40), where male=1 and female=0, age is in
years, height is in centimetres, and weight is in kilograms.
Table 2 summarises various estimated models and their fit measures. The best-fitting model to the dataset
was the additive model that includes a smooth spline transformation for age and an interaction term
between age and sex plus linear terms for weight and height. The fit of the model yields an adjusted
R2=0.57, AIC=69342.81 and BIC=69449.50. This additive model demonstrates “very strong”
improvements [34] compared with both the linear model (BIC difference=170.34) and the polynomial
model (BIC difference=81.9). The age-dependent transformations of V′O2peak are shown in figure 2.
Additionally, the linear dependencies of weight and length are shown in figures 3 and 4.
The fit of the models compared in the combined and separate paediatric and adult populations is shown
in table 3. The additive model provides the largest predictive accuracy overall with an adjusted R2=0.57
and SEE=556.50 mL·min−1 in the entire primary sample; the polynomial and the additive models
performed equally against the cross-validation sample, specifically R2=0.57 compared with the linear
model with R2=0.55. Additionally, the additive model also provided the smallest standard error of the
estimate in the stratified age groups in both samples, i.e. SEE=495.18 and 420.72 mL·min−1 in those
⩽20 years old and SEE=563.82 and 476.92 mL·min−1 in those >20 years old. The largest improvement
between models in both samples occurred in the ⩽20-year-old age group. In this age group, the additive
model has a better fit than both the linear and polynomial models, with an equal adjusted R2
difference=0.05. Similar improvements are discerned in the standard error of the estimate between the
additive and the linear and polynomial models of SEE=65.47 and 53.62 mL·min−1 in the primary sample
and SEE=108.14 and 35.81 mL·min−1 in the cross-validation sample, respectively.
Reference values with corresponding prediction intervals are constructed using average weight and height
per sex and age provided by Statistics Netherlands. Table 4 shows the predictions for the female cases and
table 5 shows the predictions for the male cases. In both sexes, the 2.5th and 97.5th prediction interval in
the 60-year-old cases is the largest: 352 mL·min−1 for the female cases and 213 mL·min−1 for the male
cases. The 2.5th and 97.5th prediction interval of the 30-year-old cases is the smallest: 131 and
78 mL·min−1, respectively. Both sexes have increasing V′O2peak prediction until the age of 20 years followed
by a decline.
TABLE 1 Sample characteristics
Primary sample Cross-validation sample














Female 907 32.2±12.8 64.3±11.8 168.6±9.3 22.5±3.0 170 23.0±9.8 61.5±14.5 166.6±12.5 21.8±3.4
Male 3570 34.6±11.5 81.6±11.6 181.7±8.1 24.6±2.6 3348 33.9±10.0 84.3±11.6 182.7±8.2 25.1±2.4
All 4477 34.1±11.8 78.1±13.6 179.1±9.9 24.2±2.9 3518 33.4±10.2 83.2±12.7 182.0±9.1 25.0±2.6
Data are presented as n or mean±SD.
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Discussion
The aim of this study was to determine reference values for V′O2peak based upon an optimal regression
model in healthy Dutch paediatric and adult populations. Based on adjusted R2, AIC, BIC and standard
error of the estimate, the additive model was the best fitting with the largest predictive accuracy. From the
model, it can be concluded that V′O2peak is sex specific and depends nonlinearly on years of age.
We determined that the additive model results in a smaller standard error of the estimate especially in the
⩽20-year-old subjects because, in contrast to the linear model, the additive model is able to adjust for
age-related transformations such as the increase in V′O2peak associated with the growth-related weight and
TABLE 2 Fitting comparison by regression model type
Estimate Standard error T-value p-value Adjusted R2 AIC BIC
Linear model
Intercept −3039.01 206.02 −14.75 <0.001 0.55 69581.40 69619.84
Sex 634.32 25.75 24.63 <0.001
Age −16.50 0.79 −20.66 <0.001
Height 29.22 1.46 19.95 <0.001
Weight 16.17 1.11 14.48 <0.001
Polynomial model
Intercept −1469.00 158.80 −9.25 <0.001 0.56 69480.15 69531.40
Sex 673.00 25.89 25.99 <0.001
Age 16.87 4.81 3.50 <0.001
Age2 −0.47 0.06 −7.31 <0.001
Height2 0.07 <0.01 16.52 <0.001
Weight 39.70 5.17 7.67 <0.001
Weight2 −0.16 0.03 −5.05 <0.001
Additive model
Intercept −2537.29 224.98 −11.28 <0.001 0.57 69342.81 69449.50
Sex 743.35 26.30 28.26 <0.001
Height 24.30 1.52 15.91 <0.001
Weight 12.57 1.12 11.21 <0.001
S(age): male 4.263# 5.260¶ 22.59+ <0.001
S(age): female 7.391# 8.288¶ 70.38+ <0.001
AIC: Akaike Information Criterion; BIC: Bayesian Information Criterion; S(age): spline function for age per sex. Sex: 0=female, 1=male;






















FIGURE 2 Age-dependent transformation of mean peak oxygen uptake (V′O2peak). Shading represents the
pointwise 95% confidence interval.
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height gain during childhood and adolescence. The increase in skeletal muscle mass during this life phase
accounts for the majority of weight gained [37]. As skeletal muscle mass is responsible for the majority of
oxygen utilised during exercise, the increase in skeletal muscle mass associated with increasing age in
⩽20-year-old subjects partially explains the increase in V′O2peak during this life phase [38]. During
adulthood, the increase in skeletal muscle mass and height are limited. V′O2peak decreases during
adulthood because of a decrease in muscle mass and a loss of chronotropic competence [24, 39].
Our additive regression model differs from previously utilised linear and polynomial regression models [9,
40, 41]. The use of the advanced statistical analysis method, GAM, in the current study makes it possible
to determine the best-fitting regression model for the combined paediatric and adult populations. This






















FIGURE 3 Relationship between mean peak oxygen uptake (V′O2peak) and weight. Shading represents the






















FIGURE 4 Relationship between mean peak oxygen uptake (V′O2peak) and height. Shading represents the
pointwise 95% confidence interval.
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cross-validation, which facilitates combining the previously hypothesised nonlinear and interrelated
fashion of more than one independent variable in the paediatric and adolescent populations, and the
curvilinear decline with age in the adult population [7, 17–20]. This method results in an improved fit
across the entire population [17, 18, 20]. Therefore, prediction of V′O2peak in the transition group between
adolescents and adulthood is more precise when using the additive model.
In comparison with the prediction models currently utilised in the Dutch clinical settings, the additive
model improves the fit in both the adult and paediatric populations. The linear prediction model for
adults provided by JONES et al. [14] yields R2=0.41 to the primary sample and R2=0.33 to the
cross-validation sample compared with R2=0.52 and 0.38, respectively, in the additive model. The linear
prediction equation provided by TEN HARKEL et al. [41] is most frequently used in the Dutch paediatric
population, this equation yields R2=0.58 and 0.73 compared with R2=0.76 and 0.84 in the primary and
TABLE 3 Fit of model type per age group and sample set
Model and age group Primary sample Cross-validation sample
Adjusted R2 SEE mL·min−1 Adjusted R2 SEE mL·min−1
Linear model
All 0.55 572.89 0.54 487.84
⩽20 years 0.71 560.65 0.81 528.86
>20 years 0.50 574.43 0.37 484.56
Polynomial model
All 0.56 566.20 0.57 476.72
⩽20 years 0.71 548.80 0.82 456.03
>20 years 0.51 568.37 0.38 478.26
Additive model
All 0.57 556.50 0.57 473.15
⩽20 years 0.76 495.18 0.84 420.72
>20 years 0.52 563.82 0.38 476.92
SEE: standard error of the estimate.
TABLE 4 Additive model peak oxygen uptake (V′O2peak) prediction percentiles: female cases
Age decile
years
Height cm Weight kg V′O2peak mL·min−1 prediction percentile
2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th
10 143.0 33.5 1581 1601 1624 1662 1704 1746 1784 1807 1826
15 164.0 52.0 2345 2359 2375 2401 2429 2458 2484 2500 2513
20 168.8 63.2 2543 2556 2570 2593 2619 2645 2668 2682 2694
30 169.3 68.5 2415 2426 2438 2458 2481 2503 2523 2536 2546
40 169.3 70.3 2298 2309 2322 2343 2367 2391 2412 2425 2436
50 167.7 70.5 2089 2104 2120 2148 2180 2211 2239 2255 2270
60 166.6 71.6 1793 1821 1854 1908 1969 2029 2084 2117 2145
TABLE 5 Additive model peak oxygen uptake (V′O2peak) prediction percentiles: male cases
Age decile
years
Height cm Weight kg V′O2peak mL·min−1 prediction percentile
2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th
10 143.0 34.0 1329 1351 1377 1421 1469 1518 1561 1587 1610
15 168.0 53.0 2775 2788 2804 2831 2860 2889 2916 2932 2945
20 183.5 78.1 3808 3816 3825 3841 3858 3875 3891 3900 3908
30 183.7 83.3 3818 3825 3832 3844 3857 3870 3882 3889 3896
40 182.4 85.1 3718 3725 3733 3747 3763 3778 3792 3800 3808
50 181.3 86.4 3292 3301 3311 3327 3346 3364 3381 3391 3399
60 179.2 84.4 2969 2986 3006 3039 3076 3112 3145 3165 3182
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cross-validation sample, respectively. These improved fits make the additive model provided by the current
study a more adequate reference prediction equation to utilise in both the paediatric and adult
populations.
Primary sample analysis and cross-validation showed consistent results, specifically a stronger predictive
accuracy in ⩽20-year-old subjects, and accuracy improvement in >20-year-old subjects and the entire
sample. This consistent increase in predictive accuracy indicates a good generalisability to the Dutch
population. This is underlined by the fit of R2=0.54 (SEE=556.55 mL·min−1) of the additive model to the
whole sample, including smokers, all BMI values and athletes. The somewhat lower adjusted R2 of the
additive model obtained in the cross-validation >20-year-old subgroup suggests a difference from the
primary sample analysis. This is possibly caused by the use of a variety of more institutions providing
>20-year-old subjects in the cross-validation sample. Every subject >20 years old in this sample was tested
at a single institute aimed at test indications such as sport- and work-related (mandatory) annual health
checks. The underrepresentation of tests initiated by a healthcare professional results in a cross-validation
sample with higher aerobic fitness compared with the more heterogeneous primary sample (healthy
workers effect).
The strength of our study is the wide age range of 7.9–65.0 years. The LowLands Fitness Registry that we
used in our study is a reasonable representation of the Dutch population. Additionally, the utilisation of a
diverse variety of healthcare centres, including hospitals, sports medicine clinics and occupational
medicine clinics, ensures representation of every conditioning status. The familiarity of the Dutch
population with cycling and the low risk of injury during testing ensures this method of measurement is
fitting for the population and participants of all ages [8].
Study results are limited by the retrospective and institution-based nature of the study. Preferably, V′O2peak
reference value research should be performed using a prospective community-based method [8], since a
retrospective study design has potential data quality issues. Although every institution used measurement
methods and equipment described by the ACCP/ATS statement [8], the exclusion of 4364 subjects
emphasises the variety of data quality in the primary sample. The majority of excluded subjects were due
to missing values, accounting for 2674 excluded subjects. It is of primary importance that CPET
instructors increase their skills and knowledge, and stringently apply the test guidelines provided by the
ATS/ACCP statement in order to facilitate data harmonisation [8].
Representative reference V′O2peak values are genuinely needed because of the current lack of reference data
in the Dutch population. The currently employed North American reference values from 1985 may
plausibly underestimate the aerobic fitness for the Dutch population; hence, subjects are misclassified as
having normal aerobic fitness. The additive regression equation presented in the current study can be used
to determine a reference value for the Dutch population. In future research aimed at determining reference
value prediction equations, the type of regression model fitted to the data may be conveniently modelled
by semiparametric regression. This research can best be performed in a prospective, community-based
setting with emphasis on the inclusion of sufficient numbers of female participants.
Conclusion
In conclusion, this study has provided a robust additive regression model for V′O2peak in the Dutch
population. V′O2peak is sex specific and has a nonlinear relationship with age. Publicly usable reference
values can be conveniently obtained by suitable software implementation.
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